Institution: | 1. Johns Hopkins University, Krieger School of Arts and Sciences, Advanced Academic Programs, Master of Science in Regulatory Science Program, Baltimore, MD, USA;2. US Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Office of Drug Evaluation 1, Division of Neurology Products, Silver Spring, MD, USA;3. Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA;4. Catalent Pharma Solutions, LLC, Woodstock, IL, USA |